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ABSTRACT   Prenatal ethanol exposure causes the reduction of serotonergic 
(5-HTergic) neurons in the midbrain raphe nuclei. In the present study, we 
examined whether an activation of signaling via 5-HT2A and 5-HT2C receptors 
during the fetal period is able to prevent the reduction of 5-HTergic neurons 
induced by prenatal ethanol exposure. Pregnant Sprague-Dawley rats were given a 
liquid diet containing 2.5 to 5.0% (w/v) ethanol on gestational days (GDs) 10 to 20 
(Et). As a pair-fed control, other pregnant rats were fed the same liquid diet except 
that the ethanol was replaced by isocaloric sucrose (Pf). Each Et and Pf group was 
subdivided into two groups; one of the groups was treated with 1 mg/kg (i.p.) of 
1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), an agonist for 5-HT2A/2C 
receptors, during GDs 13 to 19 (Et-DOI or Pf-DOI), and another was injected with 
saline vehicle only (Et-Sal or Pf-Sal). Their fetuses were removed by cesarean 
section on GD 19 or 20, and fetal brains were collected. An immunohistological 
examination of 5-HTergic neurons in the fetuses on embryonic day 20 using an 
antibody against tryptophan hydroxylase revealed that the number of 5-HTergic 
neurons in the midbrain raphe nuclei was significantly reduced in the Et-Sal 
fetuses compared to that of the Pf-Sal and Pf-DOI fetuses, whereas there were no 
significant differences between Et-DOI and each Pf control. Thus, we concluded 
that the reduction of 5-HTergic neurons that resulted in prenatal ethanol exposure 
could be alleviated by the enhancement of signaling via 5-HT2A/2C receptors during 
the fetal period.  
 
Key Words: 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, fetal ethanol, rat, 
5-HTergic neuron, midbrain raphe nuclei 
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INTRODUCTION 
Ethanol is one of the best-known substances capable of inducing developmental 
abnormalities in the central nervous system (CNS). In fact, dysfunctions of the CNS, 
such as intellectual disability, learning disorder, hyperactivity, and coordination defect, 
have been reported in children with a history of exposure to ethanol in utero. Now, it is 
widely recognized that ethanol is a main cause of intellectual disability among those of 
a known etiology, and the developmental abnormalities with functional defects of the 
CNS caused by prenatal ethanol exposure are referred to as fetal alcohol syndrome 
(FAS, Rosett 1980) or fetal alcohol spectrum disorders (FASD, Sokol et al. 2003; see 
Riley et al. 2011, for a review).  
The serotonergic (5-HTergic) system is one of the places targeted by the 
developmental neurotoxicity of ethanol. It has been widely accepted that prenatal 
ethanol exposure causes a reduction of 5-HTergic neurons in the midbrain raphe nuclei 
(Ohta et al. 2010; Tajuddin and Druse 1999, 2001; Sari and Zhou 2004; Zhou et al. 2001, 
2002, 2008). Although it is obvious that ethanol exposure during the fetal period 
induces a reduced number of 5-HTergic neurons in the midbrain raphe nuclei, its 
mechanism is still incompletely understood. 
   Serotonin (5-HT) is a monoamine neurotransmitter related to many behaviors, 
physiological functions, and psychiatric disorders, such as aggression, anxiety, stress 
response, sexual behavior, and depression (Oliver 2015), while it has been expected to 
play important roles in the immature brain (see Bonnin and Levitt 2011; 
Whitaker-Azumita et al. 1996, for reviews). For example, 5-HT inhibits growth corn 
motility and synaptogenesis (Haydon et al. 1984) and modulates responsiveness of 
thalamocortical axons to a axonal guidance cue (Bonnin et al. 2007), and lack of 5-HT 
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altered serotonergic innervations in the suprachiasmatic nucleus, praraventricular 
nucreus, nucleus accumbens, and hippocampus (Migliarini et al. 2013). Activation of 
5-HT receptors enhance neurite outgrowth and lead to neuronal survival (Fricker et al. 
2005; Lotto et al. 1999). Thus, disrupted 5-HTergic signaling during the prenatal period 
has been thought to be the possible cause of abnormal brain function in adulthood 
(Bonnin and Levitt 2011).  
   Seven families of the 5-HT receptor, comprising a total of 14 subtypes, have been 
identified (see Hoyer et al. 2002 for review), some of which already appear in the brain 
from the fetal period (Hellendall et al. 1993; Hillion et al. 1993; Johnson and 
Heinemann 1995; Bolaños-Jiménez et al. 1997). Especially, 5-HT1A receptor, which was 
identified in the cell bodies of 5-HTergic neurons in the embryonic midbrain (Héry et al. 
1999; Hillion et al. 1994), has been strongly suggested to play important roles in the 
development of the 5-HTergic neurons. Interestingly, it has been reported that 5-HT1A 
receptor is not only located on neurons but also on astrocytes (Azmitia et al. 1996) and 
it would mediate some neurotrophic effects of 5-HT (Whitaker-Azmitia et al. 1990). 
Previously, it was demonstrated that maternal treatment with a 5-HT1A receptor agonist, 
ipsapirone, during the peak of differentiation of 5-HTergic neurons prevented the 
ethanol-associated reduction of 5-HTergic neurons and astrocytes in the raphe region of 
the developing rat brain (Tajuddin et al. 2003; Tajuddin and Druse 1999, 2001). Also, in 
vitro studies showed that ipsapirone prevents the ethanol-associated increase of 
apoptosis in 5-HTergic and other neurons in the rhombencephalon (Druse et al. 2004, 
2005). Thus, it is considered that a facilitated 5-HT action via 5-HT1A receptor could 
protect 5-HTergic neurons from ethanol toxicity in fetal brain.  
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   Also other subtypes of 5-HT receptors have been considered to play key roles in 
brain development, because they were identified in the fetal brain (Gaspar et al. 2003) 
and suggested to mediate trophic effects of 5-HT (Lotto et al. 1999; Persico et al. 2006). 
Thus, it will be interesting to see if the agonists for these 5-HT receptors can prevent 
ethanol toxicity in the development of 5-HTergic neurons. Among 5-HT receptors, the 
5-HT2A receptor is the most widely distributed in the brain. The expression of 5-HT2A 
receptors in the fetal brain gradually increases from embryonic days (EDs) 11 to 21, 
with a dramatic increase to a peak at ED 13, and it then decreases by ED 17 (Wu et al. 
1999). The predominant 5-HT2 receptors in the neonatal period are 5-HT2C receptors, 
while 5-HT2A receptors become predominant as the animal ages (Ike et al. 1995). In the 
midbrain raphe nuclei of adult rats, 5-HT2C receptors have been identified in the 
majority of GABAergic neurons, even if not in 5-HTergic neurons (Serrats et al. 2005), 
and the GABAergic neurons input to 5-HTergic neurons of DR (Wang et al. 1992). In 
addition, the possibility that a 5-HT2A/2C receptor agonist promotes growth of cultured 
embryonic brainstem 5-HT cells was suggested (Whitaker-Azmita et al. 1996). Thus, it 
is of interest whether the enhancement of signaling via 5-HT2A/2C receptors during the 
fetal period has the potential to protect 5-HTergic neurons from the developmental 
toxicity of ethanol.  
   In the present study, we examined whether a 5-HT2A/2C receptor agonist, 
1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), has a preventive effect against 
the reduction of 5-HTergic neurons in the midbrain raphe nuclei resulting in prenatal 
ethanol exposure in rats. We also measured monoamines and their metabolite levels 
using high-precision liquid chromatography (HPLC), and determined the expression 
level of genes involved in the generation and differentiation of 5-HTergic neurons using 
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a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) in the whole brain 
of fetuses prenatally exposed to ethanol.  
 
MATERIALS AND METHODS 
Animals, diets, and treatment 
All animal procedures were conducted according to the Guide for the Care and Use of 
Laboratory Animals, and were reviewed by the Institutional Animal Care and Use 
Committee of the University of Tokushima. Great care was taken to minimize the 
number of animals used, and their suffering.  
Pregnant Sprague-Dawley rats were obtained from Japan SLC (Hamamatsu, Japan). 
All of the rats used for the present study were maintained under 12-hour/12-hour of 
light and dark cycle. The presence of a vaginal plug was referred to as gestational day 
(GD) 0. At first, the pregnant dams were divided into two groups; prenatal 
ethanol-exposed (Et) and pair-fed control (Pf) groups. The same procedure as described 
in our previous study (Ohta et al. 2010) was used to prepare the rats of each 
experimental group. Briefly, pregnant rats of the Et group were allowed free access to a 
liquid diet (Oriental Yeast Co., Tokyo, Japan) containing ethanol during GDs 10 to 20, 
corresponding to the second-trimester of pregnancy in human. The ethanol 
concentration of the diet was gradually raised: 2.5% (w/v) on GDs 10 to 12, 4.0% (w/v) 
on GDs 13 to 15, and 5.0% (w/v) on GDs 16 to 20, to avoid a diminishing maternal 
intake and body weight gain (Sakata-Haga et al. 2002). In our preliminary study, the 
blood ethanol concentration (BEC) at the end of dark-phase during this administration 
regimen was measured in non-pregnant female rats (n=6) by AM1 Alcohol Analyzer 
(Analox Instrument, London, UK). During the 1
st
 to 3
rd
 day, the period rats fed a diet 
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containing 2.5% ethanol, the mean of BEC was 94.5 ± 8.5 mg/dl. During the 4
th
 to 6
th
 
day, the period rats fed a diet containing 4.0% ethanol, the mean of BEC was 182.3 ± 
9.8 mg/dl. During the 7
th
 to 10
th
 day, the period rats were fed a diet containing 5.0% 
ethanol, and the mean of BEC was 266.0 ± 9.8 mg/dl. Pregnant rats of the Pf group 
were given an equivalent amount of the same liquid diet consumed by Et dams on a 
daily basis, except that the ethanol was replaced by isocaloric sucrose. Calorie content 
of both liquid diets was 1 kcal/ml. Each day between GDs 13 and 19, approximately 
half of the Pf and Et dams were given an intraperitoneal injection of a DOI solution, 
containing 1 mg of DOI hydrochloride (Sigma-Aldrich, St. Louis, MO) in 1 ml of saline, 
once a day at a daily dose of 1 mg/kg/day. Other dams of each Pf and Et group received 
only saline vehicle at the equival nt dose. DOI has a higher affinity for both 5-HT2A and 
5-HT2C (Ki value is 0.7 nM and 2.4 nM, respectively) receptors than for 5-HT2B 
receptor (Ki value is 20 nM) (Nelson et al. 1999), and it has been widely used as an 
agonist for 5-HT2A/2C receptors. DOI also has been used to examine the effect of the 
activation of 5-HT2A/2C receptors during the fetal period, because it crosses the placental 
barrier (Bou-Flores et al. 2000; Bras et al. 2008). The four treatment groups, Pf-Sal 
(n=7) Pf-DOI (n=8), Et-Sal (n=8), and Et-DOI (n=6), were established in the present 
study by the combination of maternal diet and drug treatment. On GD 19 or 20, 
pregnant dams were anesthetized and their fetuses were removed by cesarean section. 
Although it has been reported that there was a gender difference in effects of prenatal 
ethanol exposure on the development of the 5-Hergic system (Hofmann et al., 2007), 
only male fetuses were used for the present study. The brains from ED 19 fetuses, which 
were collected within 4 h after a final injection of saline or DOI to their dams, were 
used for the observation using quantitative real-time PCR. To avoid miscount of 
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5-HTergic neurons by direct effect of DOI on TPH expression and also to understand a 
change of monoamines status consequent to the DOI treatment, the brains used for the 
immunohistological detection of 5-HTergic neurons and quantification of monoamines 
and their metabolite contents were obtained from ED 20 fetuses, which were collected 
at least 24 h after a final injection of saline or DOI.  
 
Immunohistochemistry for 5-HTergic neurons in midbrain raphe nuclei 
For an immunohistological observation of 5-HTergic neurons, seven fetuses from three 
of Pf-Sal dams, seven fetuses from four of Pf-DOI dams, ten fetuses from four of Et-Sal 
dams, and seven fetuses from two of Et-DOI dams were used. The fetal brains were 
removed and immersed into 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) 
just after removal from the skull. The brains were embedded in paraffin and serially 
sliced along the frontal plane at 5-µm thickness. The sections were irradiated with 
microwaves for 5 min in 10 mM citrate buffer (pH 6.0), and then incubated with mouse 
anti-tryptophan hydroxylase (TPH) antibody (1:1000, Oncogene Research Products, 
San Diego, CA, USA) for 24 h at 4°C. Next, the sections were incubated with 
horseradish peroxidase-conjugated anti-mouse IgG antibody (1:400, MBL, Nagoya, 
Japan) for 2 h at 37°C. The immunoreactivity was then visualized with a solution 
containing 0.035 g 3,3-diaminobenzidine tetrahydrochloride (Nakarai, Kyoto, Japan), 
and 2.5 g nickel ammonium sulfate hexahydrate (Nakarai, Kyoto, Japan) in 100 ml of 
0.1 M acetate buffer for 5 min at 37°C in the presence of 0.003% H2O2. 
TPH-immunoreactive (TPH-ir) cells were counted in the dorsal raphe (DR) and the 
median raphe (MR) nuclei. At first, the most rostral section containing both DR and MR 
was identified as the first section, and every 5 sections (a total of five sections) were 
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picked and supplied for a TPH-ir cell counting procedure (Ohta et al. 2010). TPH is a 
rate-limiting enzyme for 5-HT biosynthesis and is widely used as a marker of 5-HTergic 
neurons. The monoclonal antibody used in the present study has been used to describe 
the distribution of TPH-containing neuron and to classified 5-HTergic neurons if the 
neuron was immunoreactive for TPH (Zhang et al. 2006; Zhang and Hammond 2009). 
Thus, TPH-ir neurons were considered as 5-HTergic neurons.  
 
Quantitative measurement of monoamines and their metabolites in whole brains 
For a quantification of monoamines, sixteen fetuses from two of Pf-Sal dams, eleven 
fetuses from two of Pf-DOI dams, eleven fetuses from two of Et-Sal dams, and eight 
fetuses from two of Et-DOI dams were used. Brains were quickly weighed after 
removal from the skull, frozen in liquid nitrogen, and stored at -30°C until use. Each 
brain was homogenized with 1 ml of 0.2 M perchloric acid (Wako, Osaka, Japan) 
containing 100 µM EDTA, and then 1 µl of isoproterenol (ISO) solution (100 ng/µl) was 
added to the homogenate as an internal standard. The homogenates were incubated for 
30 min on ice and centrifuged for 15 min at 20,000 ×g at 0°C. Each supernatant was 
corrected, pH was adjusted to 3.0 with 1 M sodium acetate, and filtered with a 0.45 µm 
pore-size filter (Millipore, USA). Each 10 µl of the aliquot was injected into the HPLC 
system (HTEC-500, Eicom, Kyoto, Japan) with an electrochemical detector (ECD-300, 
Eicom, Kyoto, Japan) and a reverse-phase column (EICOMPAK SC-50DS, ϕ3 
mm×150 mm, Eicom, Kyoto, Japan). As a mobile phase, a solution composed of 0.1 M 
sodium acetate-citric acid buffer with 190 mg/l sodium 1-octanesulfonate, 5 mg/l 
EDTA-2Na and 15% (vol/vol) methanol (pH 3.5), was used, and the flow rate was 
maintained at 0.5 ml/min. The detector response was plotted and measured using an 
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HPLC chromatogram analysis software Power Chrom (ver. 2.3.1, eDAQ Japan, Nagoya, 
Japan). A standard solution, containing 5-HT and its metabolite, 5-HIAA; dopamine 
(DA) and its metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC); and ISO at each 
concentration of 10 pg/µl was prepared, and 10 µl of the standard solution was applied 
to obtain a chromatogram before sample analysis. The amount of each monoamine was 
calculated from the integrated chromatographic peak area and expressed as ng/g wet 
tissue. As an index of DA and 5-HT turnover, the DOPAC/DA and 5-HIAA/5-HT ratios 
were also calculated.  
 
Quantitative real-time PCR 
Total RNA was isolated from frozen brains of 18, 11, 8 and 13 fetuses from two dams 
each in the Pf-Sal, Pf-DOI, Et-Sal and Et-DOI groups according to the manufacturer’s 
instructions with Isogen (Nippon Gene Inc., Tokyo, Japan) and quantitated by a 
spectrophotometer (Smartspec 3000, Bio-Rad Laboratories, Hercules, CA, USA; 
260/280 nm ratio). The integrity of the RNA was checked by agarose gel electrophoresis. 
First-strand cDNA was synthesized from 1 µg of total RNA using oligo (dT) and Super 
Script III First-strand Synthesis System (Invitrogen Life Tech., CA, USA). Real-time 
PCR was performed on an ABI 7500 instrument and its associated software (Applied 
Biosystems, Foster City, CA, USA). PCR reactions were performed in 20 µl solutions 
containing 2 µl of cDNA, 200 nM primer pair, and 1× SYBR green PCR master mix in 
96-well plates. The primer sets for the PCR reactions are listed in Table 1. The PCR 
cycling conditions were 95°C for 3 min, followed by 40 cycles at 95°C for 30 s, and the 
appropriate annealing temperature for the primer set under study was for 30 s and 72°C 
for 40 s (see Table 1 for annealing temperatures). For each reaction, a standard curve 
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was obtained by analyzing a dilution series of pooled cDNA samples. To correct for 
sample-to-sample variation, glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was 
used as an internal standard for RT-PCR. The expression of each target gene was 
quantified as a relative expression against the Gapdh expression. PCR product purity 
was confirmed by dissociation curve analysis for each gene at the end of the PCR 
reaction.  
 
Statistical analysis 
Statistical analyses were conducted using SPSS 16.1J (IBM Japan, Tokyo, Japan). Data 
of the cell counts, body weight, brain weight, monoamine content, and RNA expression 
were analyzed using a two-way analysis of variance (ANOVA) with factors Food and 
Treatment. When an interaction reached significance, a simple main effect test was used 
to confirm a simple main effect of each factor, while an interaction was not significant, 
Tukey test (for data sets with equal variances) or Dunnett’s T3 test (for data sets with 
unequal variance) was performed as Post-hoc analysis. Homogeneity variances were 
analyzed with Levene’s test. Results are expressed as mean ± SD. Statistical 
significance was considered at p < 0.05. 
 
RESULTS 
Body weight and brain weight of fetuses 
Body weight, brain weight, and brain to body weight ratio of fetuses at ED 20 were 
shown in Table 2. In the body weight of pups, no interaction was detected between Food 
and Treatment, and a significant main effect of Food was significant. Post-hoc analysis 
revealed that there were significant differences between PF-sal and Et-sal or Et-DOI. 
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Thus, it was suggested that prenatal ethanol exposure induced growth deficiency of 
fetuses regardless of DOI treatment. On the other hand, a significant Food and 
Treatment interaction was detected in the brain weight of pups. A simple main effect of 
Food was significant in the saline-treated group (Pf-Sal and Et-Sal) and also that of 
Treatment was significant in the non ethanol-exposed group (Pf-Sal and Pf-DOI). Thus, 
it was suggested that prenatal ethanol exposure inhibited brain growth, and the 
inhibitory effect of ethanol on fetal brain growth was not prevented by DOI. In the ratio 
of brain weight to body weight, the main effect of Food was significant, whereas the 
main effect of Treatment was not, and no interaction was detected between Food and 
Treatment. Post-hoc analysis revealed that there were significant differences between 
PF-Sal and Et-Sal or Et-DOI. Thus, it was suggested that prenatal ethanol exposure 
altered the ration of brain weight to body weight regardless of DOI treatment. 
 
Number of TPH-ir cells in raphe nuclei 
In all four experimental groups, TPH-ir cells were mainly distributed in the dorsal and 
the median raphes (DR and MR, respectively) of the midbrain (Figs. 1A and B). Fig. 2 
shows the relative numbers of these cell in each group (based on that in Pf-Sal). In both 
the DR and MR, a significant interaction of Food and Treatment was detected. A simple 
main effect of Food was confirmed in only the saline-treated group and that of 
Treatment was significant in the ethanol-exposed group in both nuclei. Thus, the present 
study suggested that prenatal ethanol exposure induced a significant decrease in the 
number of THP-ir cells in both DR and MR, while the inhibitory effect of ethanol on the 
number of 5-HTergic neurons was attenuated by co-treatment with DOI (Figs. 1 and 2).  
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Monoamine contents and their turnover in fetal brains 
Contents of DA, 5-HT, and their metabolites in whole fetal brain were shown in Table 3. 
For the contents of 5-HT or 5-HIAA in the whole fetal brains, the main effect of Food 
was significant and no interaction was detected between Food and Treatment. Post-hoc 
analysis revealed that there were significant differences between Pf-Sal and Et-Sal or 
Et-DOI and also between Pf-DOI and Et-Sal or Et-DOI. Thus, it was suggested that 
prenatal ethanol exposure induced a reduction of 5-HT content in the whole fetal brain 
regardless of DOI treatment. On the other hand, significant differences of 5-HIAA 
content were detected between Pf-Sal and Et-Sal, but not between Pf-Sal and Et-DOI. 
There results suggested that prenatal ethanol exposure without DOI treatment reduced 
5-HIAA content, but DOI treatm nt mitigated the ethanol-induced reduction of 5-HIAA 
content in the fetal whole brain. The turnover ratio of 5-HT was not altered by any 
factors of Food or Treatment. For the contents of DA in the whole fetal brains, the main 
effect of Food was significant and no interaction was detected between Food and 
Treatment. However, a significant difference was never detected between any couple of 
two experimental groups. Significant interactions between Food and Treatment were 
shown in the content of DOPAC and the turnover ratio of DA. For both DOPAC content 
and the turnover ration of DA, a simple main effect of Treatment was significant in the 
pair-fed group, but not in ethanol-exposed group. Thus it was suggested maternal DOI 
treatment facilitated turnover of DA in the fetal brain, but the prenatal ethanol-exposure 
interrupted the DOI efficacy. 
 
Expression of genes related to generation and differentiation of 5-HTergic neurons  
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Changes of gene expression in whole fetal brain on GD 19 were shown in Fig. 3. For 
expression of Phox2b and Lmx1b, a significant interaction between Food and Treatment 
was detected. Whereas a simple main effect of Food was confirmed in both the saline- 
or DOI-treated groups, a simple main effect of Treatment was significant only the 
ethanol-exposed group. For relative expression of Lmx1b, a simple main effect of Food 
was significant in the saline-treated group, and also that of Treatment was significant 
only the ethanol-exposed group. It was suggested that prenatal ethanol-exposure 
suppressed relative expressions of Phox2b and Lmx1b, however, the ethanol-induced 
reductions of each Phox2b and Lmx1b expression were completely prevented by 
co-treatment of dams with DOI. For expression of Fgf8, the main effect of Food was 
significant and no interaction was detected between Food and Treatment. However, a 
significant difference was never detected between any couple of two experimental 
groups in post-hoc analysis. For expression of Nkx2.2, the main effect of Treatment was 
significant and no interaction was detected between Food and Treatment. Post-hoc 
analysis revealed that there were significant differences between Et-DOI and PF-Sal or 
Et-Sal. Thus, it was suggested that DOI treatment reduced relative expression of Nkx2.2, 
regardless ethanol exposure in utero. 
    
 
DISCUSSION 
In the present study, we found that a 5-HT2A/2C receptor agonist, DOI, had the ability to 
prevent a reduction in 5-HTergic neurons in the DR and MR induced by prenatal 
ethanol treatment. Previously, Tajuddin and colleagues reported that maternal treatment 
with a 5-HT1A receptor agonist, ipsapirone, during the peak of differentiation of 
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5-HTergic neurons prevented the ethanol-associated reduction of 5-HTergic neurons in 
the midbrain raphe nuclei (Tajuddin and Druse 1999, 2001; Tajuddin et al. 2003). The 
present study suggested that also an agonist of 5-HT2A/2C receptors also protect midbrain 
5-HTergic neurons from developmental neurotoxicity of ethanol.  
   A mechanism of the protective effect of DOI against the developmental toxicity of 
ethanol might be more complicated than that of 5-HT1A receptor agonists, because 
5-HT2A and 5-HT2C receptors have never been identified on 5-HTergic neurons in the 
immature mesencephalon, and the distribution of these receptors during brain 
development remains incompletely defined, unlike that of 5-HT1A receptor. In addition, 
prenatal ethanol exposure has no apparent effect on expression of mRNA for 5-HT2A or 
5-HT2C receptors in rats (Kim et al. 1997; Hofmann et al. 2007), whereas ethanol 
exposure in utero impairs the development of 5-HT1A receptor-expressing neurons in 
the parietal and frontal cortex. However, 5-HT signaling via 5-HT2A and 5-HT2C 
receptors must be important for normal brain development, as evidenced by the fact that 
both receptors are expressed in immature brain with developmental stage-related 
changes (Ike et al. 1995; Wu et al. 1999) and would mediate trophic effects of 5-HT 
(Persico et al. 2006).  
It was reported that mRNA of both 5-HT2A and 5-HT2C receptors are expressed in 
the DR and periaqueductal gray, that is adjacent to the DR, in adult rats (Wright et al. 
1995). Subsequently, it was demonstrated that 5-HT2C receptors were mainly distributed 
in GABAergic neurons in the midbrain raphe nuclei, even if they were not in 5-HTergic 
cells (Serrats et al. 2005). 5-HTergic neurons of the DR receive input from GABAergic 
neurons via GABAA receptors (Wang et al. 1992), and an activation of 5-HT2A and 
5-HT2C receptors by DOI administration increases inhibitory input from GABAergic 
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neurons to 5-HTergic neurons of the DR (Liu et al. 2000). It was reported that GABA 
acted as a neurotrophic factor against immature monoamine neurons, including 
5-HTergic neurons, and regulated their survival in an in vitro study using primary 
dissociated cells from rat fetuses on ED 14 (Liu et al. 1997). Therefore, the protective 
effect of DOI against the reducing of 5-HTergic cells by prenatal ethanol exposure 
might be exerted through activation of GABA neurons in the raphe nuclei.  
In quantitative measurement of their monoamines, it was revealed that prenatal 
ethanol administration induced decreases in the content of both 5-HT and 5-HIAA in the 
whole brain. DOI supplementation tended to mitigate the reduction of 5-HT content, 
however this DOI effect was not statistically significant. On the other hand, DOI 
treatment improved 5-HIAA cont nt in the ethanol-exposed fetus. Thus, it was 
suggested that DOI treatment was effective to protect developing 5-HTergic system 
from ethanol toxicity, while it might be not enough.  
Quantitative real-time PCR revealed the expression status of genes involved 
serotonergic differentiation on ED 19. In rats, the peak of 5-HTergic differentiation 
takes place at EDs 15 to16, and shows an assembled distribution of 5-HTergic neurons 
with adult by ED 19. Hence, differentiation into 5-HTergic neurons is due to be 
completed by ED 19 in rats. Thus, these gene expressions in rats at ED 19 may show the 
results of the altered differentiation into 5-HTergic neurons. Et-Sal rats displayed 
significantly lower levels of Phox2b mRNA expression than both Pf-Sal and Et-DOI. 
Phox2b is a molecule that suppresses the premitotic cell differentiation into 5-HTergic 
neurons and expression of Phxo2b is suppressed in differentiating 5-HTergic neurons 
(Pattyn et al. 2003). Thus, the changes in relative expression of Phox2b seen in our 
study might reflect the changes in the number of differentiated 5-HTergic neurons 
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depending on foods and treatments. Also, Lmx1b, which was expressed in postmitotic 
5-HTergic neurons (Hendricks et al. 1999, 2003), showed parallel changes with the 
number of 5-HTergic neurons. As expected, relative expression of Lmx1b in Et-Sal rats 
was significantly lower than that of Pf-Sal or Et-DOI. Expression of Fgf8, which 
reported a reduced expression after prenatal ethanol exposure, was reduced in fetal brain 
by prenatal ethanol exposure. On the other hand, expression of Shh, which also reported 
prenatal ethanol-related change, was not affected in the present study. However, a time 
series comparison from earlier stage of development and observation of 5-HTergic cell 
specific changes would be required to understand the correlation of these genes in the 
ethanol-induced reduction of 5-HTergic neurons and its prevention by DOI.  
In the present study, we sugg sted that enhancement of signaling via 5-HT2A and/or 
5-HT2c receptors could possibly prevent the reduction of 5-HTergic neurons induced by 
prenatal ethanol exposure. The protective effects of the 5-HT2A /2C agonist on the 
ethanol-induced reduction of 5-HTergic neurons would be exerted through direct and/or 
indirect actions on 5HTergic neurons, such as GABAergic neurons and/or astrocytes. To 
further understand these mechanisms, it is also important to know in detail the roles of 
each 5-HT2A or 5-HT2C receptor in brain development, particularly in development of 
the 5-HTergic system.  
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Fig. 1  A: Sketch of a frontal plane containing the dorsal raphe (DR) and the median 
raphe (MR). B: Distribution of TPH-ir cells in the midbrain raphe nuclei on a 
frontal section of rat fetus on GD 20 (A scale bar = 400 µm). The DR and MR 
of rat fetus on prenatal day 20 were identified by reference to an atlas for 
prenatal rat brain (Foster 1998). C and D: Comparison of TPH-ir cell 
distribution in the DR and MR among experimental groups, respectively (Scale 
bars = 100 µm). In both the DR and MR, Et-DOI fetuses showed a pronounced 
reduction in TPH-ir cells compared to all other groups. Aq, aqueduct; mlf, 
medial longitudinal fasciculus; xscp, decussation of the superior cerebellar 
peduncle. 
 
Fig. 2  Comparison of TPH-ir cell numbers in DR and MR among experimental groups. 
Values are represented as mean + SD of percentage of relative expression in 
Pf-Sal. 
●●
p < 0.01 for a significant simple main effect of Food. 
▲
p < 0.05 or 
▲▲
p < 0.01 for a significant simple main effect of Treatment.  
         The number of TPH-ir cells in both the DR and MR showed a significant 
Food and Treatment interaction [F(1, 27) = 5.54, p < 0.05 and F(1, 27) = 5.31, p < 
0.05, respectively]. A simple main effect of Food in the saline-treated group 
(Pf-sal and Et-sal) was significant in both DR and MR [F(1, 27) = 19.83, p < 0.01 
and F(1, 27) = 27.01, p < 0.01, respectively]. Also, a simple main effects of 
Treatment was significant in the ethanol-exposed group (Et-Sal and Et-DOI) in 
both DR and MR [F(1, 27) = 6.17, p < 0.05 and F(1, 27) = 10.17, p < 0.01, 
respectively]. Thus, it was suggested that DOI treatment could protect 
ethanol-induced reduction of 5-HTergic neurons in both DR and MR.  
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Fig. 3  Gene expression of Shh, Fgf8, transcription factors involved in serotonergic 
neuron development (Phox2b, Nkx2.2, Gata2, Lmx1b and Pet1) in whole fetal 
brains. Values are represented as mean + SD of percentage of relative 
expression in Pf-Sal. 
●
p < 0.05 or 
●●
p < 0.01 for a significant simple main effect 
of Treatment. 
▲
p < 0.05 or 
▲▲
p < 0.01 for a significant simple main effect of 
Treatment. *p < 0.05 compared to Pf-Sal. 
#
p < 0.05 compared to Et-Sal.
 
   For expression of Phox2b and Lmx1b, a significant interaction between 
Food and Treatment was detected [F(1, 46) = 16.95, p < 0.01 and F(1, 46) = 6.53, p 
< 0.05, respectively]. For Phox2b expression, a simple main effect of Food in 
both saline treated groups (Pf-sal and Et-sal) and DOI treated groups (Pf-DOI 
and Et-DOI) was significant [F(1, 46) = 11.40, p < 0.01 and F(1, 46) = 5.90, p < 
0.05, respectively] , and a simple main effects of Treatment was significant in 
ethanol-exposed groups (Et-Sal and Et-DOI) was significant [F(1, 46) = 17.29, p 
< 0.01 ]. For Lmx1b expression, a simple main effect of Food in saline treated 
groups (Pf-sal and Et-sal) was significant [F(1, 46) = 7.01, p < 0.05] , and a 
simple main effects of Treatment was significant in ethanol-exposed groups 
(Et-Sal and Et-DOI) was significant [F(1, 46) = 5.22, p < 0.05 ]. For expression 
of Fgf8, the main effect of Food was significant [F(1, 46) = 6.48, p < 0.05], 
whereas that of Treatment was not, and interaction of Food and Treatment was 
also not significant. Post-hoc analysis showed no significant differences 
between any two groups. On the other hand, expression of Nkx2.2 was 
significantly affected by Treatment [F(1, 46) = 9.98, p < 0.01], but not by Food, 
and interaction of Food and Treatment was also not significant. Post-hoc 
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analysis detected significant differences between Et-DOI and Pf-Sal or Et-Sal 
(p < 0.05 and p < 0.05, respectively). For expressions of Shh, Gata2, and Pet1, 
the main effects of each Food and Treatment were not significant, and 
interactions of Food and Treatment were also not significant. 
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Table 1 List of primer pairs used in quantitative real-time PCR  
Genes  Sequence 5'→3' 
Amplicon 
  size (bp) 
   Annealing 
temperature (°C) 
Gapdh 
Forward 
Reverse 
AGACAGCCGCATCTTCTTGT 
TGATGGCAACAATGTCCACT 
142 58 
Shh 
Forward 
Reverse 
AGGCTGGATTCGACTGGGTCTA 
AACTTGGTGCCACCCTGCTC 
142 64 
Fgf8 
Forward 
Reverse 
CATCAACGCCATGGCAGAA 
CAGCACGATCTCCGTGAACA 
187 64 
Phox2b 
Forward 
Reverse 
TACGCCGCAGTTCCATACAAACTC 
TCTTTGAGCTGCGCGCTTGTGAAG 
104 56 
Nkx2.2 
Forward 
Reverse 
CATGTCGCTGACCAACACAAAG 
TCGCTGCTGTCGTAGAAAGGA 
210 56 
Gata2 
Forward 
Reverse 
GTGGAACGTACTCTTGGCTCCTG 
TCCAAACAAACACTGTCCGTGAA 
196 64 
Lmx1b 
Forward 
Reverse 
TCAGTGTGCGTGTGGTCCAG 
TCTGCTGCTCTTGCTGTTGC 
93 64 
Pet1 
Forward 
Reverse 
CCCTGCTGATCAACATGTACCTACC 
CAGCTCCAGTAGAAACTGCCACAA 
143 60 
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Table 2 Body weight, brain weight, and brain to body weight ratio of fetuses  
 
Pf-Sal 
(n = 16) 
Pf-DOI 
(n = 11) 
Et-Sal 
(n = 11) 
Et-DOI 
(n = 8) 
Body weight (g) 3.987 ± 0.413 3.671 ± 0.166 3.440 ± 0.222** 3.409 ± 0.196** 
Brain weight (g) 0.181 ± 0.007●●,▲ 0.175 ± 0.008▲ 0.170 ± 0.004●● 0.172 ± 0.007 
Brain/Body weight ratio (%) 4.59 ± 0.39 4.76 ± 0.12 4.96 ± 0.27* 5.06 ± 0.29* 
Values are reported as mean ± SD. *p < 0.05 or **p < 0.01 compared to Pf-Sal. ●●p < 0.01 for a significant simple 
main effect of Food between the saline-treated groups. ▲p < 0.05 for a significant simple main effect of Treatment 
between the pair-fed controls. In the body weight of pups, no interaction was detected between Food and Treatment, 
and a significant main effect of Food [F(1, 42), = 20.72, p < 0.01], but not of Treatment, was detected. Post-hoc analysis 
revealed there were significant differences between Pf-Sal and Et-Sal (p < 0.01) or Et-DOI (p < 0.01), respectively. In 
the brain weight of pups, a significant Food and Treatment interaction was detected. A simple main effect of Food in 
the saline-treated group (Pf-Sal and Et-Sal) [F(1, 42), = 19.12, p < 0.01] and that of Treatment in the pair-fed control 
(Pf-Sal and Pf-DOI) [F(1, 42), = 7.06, p < 0.05], was significant. In the brain/body weight ratio, no interaction was 
detected between Food and Treatment, and a significant main effect of Food [F(1, 42), = 14.04, p < 0.01], but not of 
Treatment, was detected. Post-hoc analysis revealed there were significant differences between Pf-Sal and Et-Sal (p < 
0.05) or Et-DOI (p < 0.05), respectively.  
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Table 3 Monoamine levels and their turnover ratios in whole brain of rat fetuses  
  
Pf-Sal 
(n = 16) 
Pf-DOI 
(n = 11) 
Et-Sal 
(n = 11) 
Et-DOI 
(n = 8) 
Contents of 
monoamine 
(ng/g wet tissue) 
5-HT 193.4 ± 17.9 194.5 ± 20.2 152.0 ± 22.1**, ## 168.5 ± 23.2*, # 
5-HIAA 313.7 ± 62.3 339.5 ± 86.3 252.7 ± 43.7* 290.1 ± 75.5 
DA 139.0 ± 23.9 154.1 ± 17.8 134.3 ± 22.4 131.5 ± 18.0 
DOPAC 23.4 ± 13.8▲ 37.6 ± 15.2▲ 30.8 ± 17.9 23.4 ± 13.8 
Turnover ratio 
5-HIAA/5-HT 1.61 ± 0.19 1.73 ± 0.33 1.67 ± 0.19 1.70 ± 0.26 
DOPAC/DA 0.16 ± 0.07▲ 0.24 ± 0.08▲ 0.22 ± 0.10 0.17 ± 0.08 
Values are reported as mean ± SD. *p < 0.05 or **p < 0.01 compared to Pf-Sal. #p < 0.05 or ##p < 0.01 compared to 
Pf-DOI. ▲p < 0.05 for a significant simple main effect of Treatment in the pair-fed group (Pf-Sal and Pf-DOI). For 
the contents of 5-HT or 5-HIAA in the whole fetal brains, no interaction was detected between Food and Treatment, 
and the main effect of Food was significant [F(1, 42), = 29.43, p < 0.01 and F(1, 42), = 7.24, p < 0.05, respectively], 
whereas the main effect of Treatment was not significant. Post-hoc analysis revealed there were significant 
differences of 5-HT content between Pf-Sal and Et-Sal (p < 0.01) or Et-DOI (p < 0.05), respectively, and between 
Pf-DOI and Et-Sal (p < 0.01) or Et-DOI (p < 0.05), respectively. Meanwhile. a significant difference of 5-HIAA 
content was detected only between Pf-Sal and Et-Sal (p < 0.05). For the turn over ratio of 5-HT, the main effects of 
Food or Treatment were not significant, and no interaction was detected between Food and Treatment. For the 
contents of DA, no interaction was detected between Food and Treatment, and the main effect of Food was 
significant [F(1, 42), = 4.46, p < 0.05], whereas the main effect of Treatment was not significant. However, there were 
no significant differences between any two groups. On the other hand, significant interactions between Food and 
Treatment were shown in the content of DOPAC and the turnover ratio of DA [F(1, 42), = 5.49, p < 0.05, or F(1, 42), = 
6.83, p < 0.05, respectively]. A simple main effect of Treatment was significant in the pair-fed group [F(1, 42), = 5.72, p 
< 0.05, or F(1, 42), = 6.50, p < 0.05, respectively].  
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